
### [MONDO:0015087](http://purl.obolibrary.org/obo/MONDO_0015087)
**Label:** autosomal dominant complex spastic paraplegia

**Subclasses:** [MONDO:0018644](http://purl.obolibrary.org/obo/MONDO_0018644) (autosomal dominant complex spastic paraplegia type 9B), [MONDO:0018005](http://purl.obolibrary.org/obo/MONDO_0018005) (spastic paraplegia-Paget disease of bone syndrome), [MONDO:0008440](http://purl.obolibrary.org/obo/MONDO_0008440) (spastic paraplegia-nephritis-deafness syndrome), [MONDO:0013132](http://purl.obolibrary.org/obo/MONDO_0013132) (hereditary spastic paraplegia 36), [MONDO:0010043](http://purl.obolibrary.org/obo/MONDO_0010043) (hereditary spastic paraplegia 17), [MONDO:0008442](http://purl.obolibrary.org/obo/MONDO_0008442) (spastic paraplegia-neuropathy-poikiloderma syndrome), [MONDO:0008443](http://purl.obolibrary.org/obo/MONDO_0008443) (spastic paraplegia-precocious puberty syndrome), [MONDO:0017275](http://purl.obolibrary.org/obo/MONDO_0017275) (spastic paraplegia-facial-cutaneous lesions syndrome), [MONDO:0015091](http://purl.obolibrary.org/obo/MONDO_0015091) (autosomal dominant spastic paraplegia type 9), [MONDO:0008439](http://purl.obolibrary.org/obo/MONDO_0008439) (spastic paraplegia-epilepsy-intellectual disability syndrome), [MONDO:0011006](http://purl.obolibrary.org/obo/MONDO_0011006) (hereditary spastic paraplegia 9A), [MONDO:0012334](http://purl.obolibrary.org/obo/MONDO_0012334) (hereditary spastic paraplegia 29), [MONDO:0012867](http://purl.obolibrary.org/obo/MONDO_0012867) (hereditary spastic paraplegia 38), 

**Mapped go classes:** [GO:0019915](http://purl.obolibrary.org/obo/GO_0019915) (lipid storage), [GO:0006561](http://purl.obolibrary.org/obo/GO_0006561) (proline biosynthetic process), [GO:0045444](http://purl.obolibrary.org/obo/GO_0045444) (fat cell differentiation), [GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function), [GO:0000166](http://purl.obolibrary.org/obo/GO_0000166) (nucleotide binding), [GO:0005524](http://purl.obolibrary.org/obo/GO_0005524) (ATP binding), [GO:0006536](http://purl.obolibrary.org/obo/GO_0006536) (glutamate metabolic process), [GO:0003723](http://purl.obolibrary.org/obo/GO_0003723) (RNA binding), [GO:0017084](http://purl.obolibrary.org/obo/GO_0017084) (delta1-pyrroline-5-carboxylate synthetase activity), [GO:0016491](http://purl.obolibrary.org/obo/GO_0016491) (oxidoreductase activity), [GO:0019240](http://purl.obolibrary.org/obo/GO_0019240) (citrulline biosynthetic process), [GO:0003824](http://purl.obolibrary.org/obo/GO_0003824) (catalytic activity), [GO:0005829](http://purl.obolibrary.org/obo/GO_0005829) (cytosol), [GO:0034389](http://purl.obolibrary.org/obo/GO_0034389) (lipid particle organization), [GO:0016310](http://purl.obolibrary.org/obo/GO_0016310) (phosphorylation), [GO:0050995](http://purl.obolibrary.org/obo/GO_0050995) (negative regulation of lipid catabolic process), [GO:0055129](http://purl.obolibrary.org/obo/GO_0055129) (L-proline biosynthetic process), [GO:0042802](http://purl.obolibrary.org/obo/GO_0042802) (identical protein binding), [GO:0006592](http://purl.obolibrary.org/obo/GO_0006592) (ornithine biosynthetic process), [GO:0009266](http://purl.obolibrary.org/obo/GO_0009266) (response to temperature stimulus), [GO:0008152](http://purl.obolibrary.org/obo/GO_0008152) (metabolic process), [GO:0004350](http://purl.obolibrary.org/obo/GO_0004350) (glutamate-5-semialdehyde dehydrogenase activity), [GO:0005783](http://purl.obolibrary.org/obo/GO_0005783) (endoplasmic reticulum), [GO:0008652](http://purl.obolibrary.org/obo/GO_0008652) (cellular amino acid biosynthetic process), [GO:0005743](http://purl.obolibrary.org/obo/GO_0005743) (mitochondrial inner membrane), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0050661](http://purl.obolibrary.org/obo/GO_0050661) (NADP binding), [GO:0004349](http://purl.obolibrary.org/obo/GO_0004349) (glutamate 5-kinase activity), [GO:0031966](http://purl.obolibrary.org/obo/GO_0031966) (mitochondrial membrane), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0016042](http://purl.obolibrary.org/obo/GO_0016042) (lipid catabolic process), [GO:0006629](http://purl.obolibrary.org/obo/GO_0006629) (lipid metabolic process), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0005739](http://purl.obolibrary.org/obo/GO_0005739) (mitochondrion), [GO:0030176](http://purl.obolibrary.org/obo/GO_0030176) (integral component of endoplasmic reticulum membrane), [GO:0016021](http://purl.obolibrary.org/obo/GO_0016021) (integral component of membrane), [GO:0055114](http://purl.obolibrary.org/obo/GO_0055114) (oxidation-reduction process), [GO:0016740](http://purl.obolibrary.org/obo/GO_0016740) (transferase activity), [GO:0016301](http://purl.obolibrary.org/obo/GO_0016301) (kinase activity), 

**Class expressions from DL-Learner:**

- [GO:0055129](http://purl.obolibrary.org/obo/GO_0055129) (L-proline biosynthetic process) 56.25%
- [GO:0019240](http://purl.obolibrary.org/obo/GO_0019240) (citrulline biosynthetic process) 56.25%
- [GO:0019202](http://purl.obolibrary.org/obo/GO_0019202) (amino acid kinase activity) 56.25%
- [GO:0017084](http://purl.obolibrary.org/obo/GO_0017084) (delta1-pyrroline-5-carboxylate synthetase activity) 56.25%
- [GO:0006592](http://purl.obolibrary.org/obo/GO_0006592) (ornithine biosynthetic process) 56.25%
- [GO:0006561](http://purl.obolibrary.org/obo/GO_0006561) (proline biosynthetic process) 56.25%
- [GO:0005743](http://purl.obolibrary.org/obo/GO_0005743) (mitochondrial inner membrane) 56.25%
- [GO:0005524](http://purl.obolibrary.org/obo/GO_0005524) (ATP binding) 56.25%
- [GO:0004350](http://purl.obolibrary.org/obo/GO_0004350) (glutamate-5-semialdehyde dehydrogenase activity) 56.25%
- [GO:0004349](http://purl.obolibrary.org/obo/GO_0004349) (glutamate 5-kinase activity) 56.25%
- [GO:0032559](http://purl.obolibrary.org/obo/GO_0032559) (adenyl ribonucleotide binding) and [GO:0035639](http://purl.obolibrary.org/obo/GO_0035639) (purine ribonucleoside triphosphate binding) 56.25%
- [GO:0030554](http://purl.obolibrary.org/obo/GO_0030554) (adenyl nucleotide binding) and [GO:0035639](http://purl.obolibrary.org/obo/GO_0035639) (purine ribonucleoside triphosphate binding) 56.25%
- [GO:0019866](http://purl.obolibrary.org/obo/GO_0019866) (organelle inner membrane) and [GO:0044444](http://purl.obolibrary.org/obo/GO_0044444) (cytoplasmic part) 56.25%
- [GO:0019866](http://purl.obolibrary.org/obo/GO_0019866) (organelle inner membrane) and [GO:0044429](http://purl.obolibrary.org/obo/GO_0044429) (mitochondrial part) 56.25%
- [GO:0019866](http://purl.obolibrary.org/obo/GO_0019866) (organelle inner membrane) and [GO:0031966](http://purl.obolibrary.org/obo/GO_0031966) (mitochondrial membrane) 56.25%


